USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
14.43
-0.13 (-0.89%)
At close: Sep 3, 2026, 4:00 PM EDT
14.43
0.00 (0.00%)
After-hours: Sep 3, 2026, 4:20 PM EDT

USANA Health Sciences Cash Flow Statement

Millions USD. Fiscal year is Feb - Jan.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
-22.1610.7642.0363.7969.35116.51
Depreciation & Amortization
38.8139.722.2320.421.4122.19
Loss (Gain) From Sale of Assets
-2.1-2.0900.010.140.06
Asset Writedown & Restructuring Costs
36.16.97----
Stock-Based Compensation
14.1813.8314.5614.613.3314.3
Other Operating Activities
-7.25-3.74-4.82-0.15-1.11.23
Change in Inventory
-12.28-34.69-2.122.3515.8-14.7
Change in Accounts Payable
-2.475.2-1.27-0.43-2.66-4.57
Change in Other Net Operating Assets
-14.34-13.6-9.62-29.92-12.37-13.79
Operating Cash Flow
27.7322.3560.9970.64103.9121.23
Operating Cash Flow Growth
-56.00%-63.36%-13.66%-32.01%-14.29%-24.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-11.79-13.82-10.07-14.49-10.4-12.76
Sale of Property, Plant & Equipment
3.973.910.060.020.010.02
Cash Acquisitions
---203.34--6.53-
Other Investing Activities
-0.92-0.210.262.54.56-1.44
Investing Cash Flow
-8.74-10.13-213.09-11.98-12.37-14.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Short-Term Debt Issued
-17.623.691.5411-
Total Debt Issued
2517.623.691.5411-
Short-Term Debt Repaid
--26.6-1.47-0.75-11-
Total Debt Repaid
-25-26.6-1.47-0.75-11-
Net Debt Issued (Repaid)
--922.220.79--
Repurchase of Common Stock
-2.45-29.85-12.67-14.69-30.09-181.41
Other Financing Activities
-2.75-1.75--0.34--
Financing Cash Flow
-5.19-40.69.55-14.24-30.09-181.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
3.595.11-6.19-2.5-13.782.09
Net Cash Flow
17.38-23.27-148.7441.9347.67-72.28

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
15.938.5350.9256.1593.5108.46
Free Cash Flow Growth
-68.75%-83.26%-9.31%-39.95%-13.79%-25.36%
Free Cash Flow Margin
1.75%0.92%5.96%6.10%9.36%9.14%
Free Cash Flow Per Share
0.870.462.662.904.845.33
Levered Free Cash Flow
49.1336.8563.161.35104.19112.81
Unlevered Free Cash Flow
49.3937.3763.2861.51104.31112.84

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Cash Interest Paid
0.470.660.080.070.050.01
Cash Income Tax Paid
34.637.1840.442.3345.7559.33
Change in Working Capital
-29.86-43.08-13-280.77-33.06
SEC Filings: 10-K · 10-Q